Case Report: Coexistence of Anti-AMPA Receptor Encephalitis and Positive Biomarkers of Alzheimer's Disease
Anti–α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis is a rare autoimmune disease that is characterized by acute cognitive impairment, mental symptoms, and seizures. The high comorbidity rate between anti–AMPA receptor (AMPAR) encephalitis and other somatic diseases...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2021.673347/full |
id |
doaj-19490111966d46548de786b754a0bcc7 |
---|---|
record_format |
Article |
spelling |
doaj-19490111966d46548de786b754a0bcc72021-07-02T05:25:57ZengFrontiers Media S.A.Frontiers in Neurology1664-22952021-07-011210.3389/fneur.2021.673347673347Case Report: Coexistence of Anti-AMPA Receptor Encephalitis and Positive Biomarkers of Alzheimer's DiseaseYu Song0Shanshan Chen1Ju Gao2Jie Lu3Wenwen Xu4Xingjian Lin5Jiu Chen6Jiu Chen7Department of Neurology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Neurology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Geriatric Psychiatry, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Neurology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Neurology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Neurology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, ChinaInstitute of Neuropsychiatry, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, ChinaInstitute of Brain Functional Imaging, Nanjing Medical University, Nanjing, ChinaAnti–α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis is a rare autoimmune disease that is characterized by acute cognitive impairment, mental symptoms, and seizures. The high comorbidity rate between anti–AMPA receptor (AMPAR) encephalitis and other somatic diseases, such as malignancy, has revealed the possibility of potential copathogenesis. However, there have not yet been reports about anti-AMPAR encephalitis with concomitant cerebrospinal fluid (CSF) biomarkers consistent with Alzheimer disease (AD). Herein, we present the case of an elderly male patient with autoimmune encephalitis (AE) presenting with anti–AMPA1-R and anti–AMPA2-R antibodies, as well as CSF biomarkers of AD. The patient was hospitalized with acute memory decline for 1 week. Anti–AMPA1-R and anti–AMPA2-R antibodies were positively detected in CSF, and the anti–AMPA2-R antibody was also present in the serum. Additionally, the biomarkers of AD were concurrently present in CSF (Aβ1−42 = 245.70 pg/mL, t-Tau = 894.48 pg/mL, p-Tau = 78.66 pg/mL). After administering a combined treatment of intravenous immunoglobulin and glucocorticoids, the patient recovered significantly, and his cognitive function achieved a sustained remission during 2 months' follow-up. This case raises the awareness of a possible interaction between AE and changes of CSF biomarkers. We speculated that the existence of AMPAR antibodies can induce changes of CSF, and other pathological alterations. This present report highlights that a potential relationship exists among AE and provides a warning when making the diagnosis of AD.https://www.frontiersin.org/articles/10.3389/fneur.2021.673347/fullautoimmune encephalitisanti-α-amino-3-hydroxy-5-methyl-4-lsoxazolepropionic acid receptorAlzheimer's diseasecognitive impairmentcerebrospinal fluid biomarkers |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yu Song Shanshan Chen Ju Gao Jie Lu Wenwen Xu Xingjian Lin Jiu Chen Jiu Chen |
spellingShingle |
Yu Song Shanshan Chen Ju Gao Jie Lu Wenwen Xu Xingjian Lin Jiu Chen Jiu Chen Case Report: Coexistence of Anti-AMPA Receptor Encephalitis and Positive Biomarkers of Alzheimer's Disease Frontiers in Neurology autoimmune encephalitis anti-α-amino-3-hydroxy-5-methyl-4-lsoxazolepropionic acid receptor Alzheimer's disease cognitive impairment cerebrospinal fluid biomarkers |
author_facet |
Yu Song Shanshan Chen Ju Gao Jie Lu Wenwen Xu Xingjian Lin Jiu Chen Jiu Chen |
author_sort |
Yu Song |
title |
Case Report: Coexistence of Anti-AMPA Receptor Encephalitis and Positive Biomarkers of Alzheimer's Disease |
title_short |
Case Report: Coexistence of Anti-AMPA Receptor Encephalitis and Positive Biomarkers of Alzheimer's Disease |
title_full |
Case Report: Coexistence of Anti-AMPA Receptor Encephalitis and Positive Biomarkers of Alzheimer's Disease |
title_fullStr |
Case Report: Coexistence of Anti-AMPA Receptor Encephalitis and Positive Biomarkers of Alzheimer's Disease |
title_full_unstemmed |
Case Report: Coexistence of Anti-AMPA Receptor Encephalitis and Positive Biomarkers of Alzheimer's Disease |
title_sort |
case report: coexistence of anti-ampa receptor encephalitis and positive biomarkers of alzheimer's disease |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Neurology |
issn |
1664-2295 |
publishDate |
2021-07-01 |
description |
Anti–α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis is a rare autoimmune disease that is characterized by acute cognitive impairment, mental symptoms, and seizures. The high comorbidity rate between anti–AMPA receptor (AMPAR) encephalitis and other somatic diseases, such as malignancy, has revealed the possibility of potential copathogenesis. However, there have not yet been reports about anti-AMPAR encephalitis with concomitant cerebrospinal fluid (CSF) biomarkers consistent with Alzheimer disease (AD). Herein, we present the case of an elderly male patient with autoimmune encephalitis (AE) presenting with anti–AMPA1-R and anti–AMPA2-R antibodies, as well as CSF biomarkers of AD. The patient was hospitalized with acute memory decline for 1 week. Anti–AMPA1-R and anti–AMPA2-R antibodies were positively detected in CSF, and the anti–AMPA2-R antibody was also present in the serum. Additionally, the biomarkers of AD were concurrently present in CSF (Aβ1−42 = 245.70 pg/mL, t-Tau = 894.48 pg/mL, p-Tau = 78.66 pg/mL). After administering a combined treatment of intravenous immunoglobulin and glucocorticoids, the patient recovered significantly, and his cognitive function achieved a sustained remission during 2 months' follow-up. This case raises the awareness of a possible interaction between AE and changes of CSF biomarkers. We speculated that the existence of AMPAR antibodies can induce changes of CSF, and other pathological alterations. This present report highlights that a potential relationship exists among AE and provides a warning when making the diagnosis of AD. |
topic |
autoimmune encephalitis anti-α-amino-3-hydroxy-5-methyl-4-lsoxazolepropionic acid receptor Alzheimer's disease cognitive impairment cerebrospinal fluid biomarkers |
url |
https://www.frontiersin.org/articles/10.3389/fneur.2021.673347/full |
work_keys_str_mv |
AT yusong casereportcoexistenceofantiampareceptorencephalitisandpositivebiomarkersofalzheimersdisease AT shanshanchen casereportcoexistenceofantiampareceptorencephalitisandpositivebiomarkersofalzheimersdisease AT jugao casereportcoexistenceofantiampareceptorencephalitisandpositivebiomarkersofalzheimersdisease AT jielu casereportcoexistenceofantiampareceptorencephalitisandpositivebiomarkersofalzheimersdisease AT wenwenxu casereportcoexistenceofantiampareceptorencephalitisandpositivebiomarkersofalzheimersdisease AT xingjianlin casereportcoexistenceofantiampareceptorencephalitisandpositivebiomarkersofalzheimersdisease AT jiuchen casereportcoexistenceofantiampareceptorencephalitisandpositivebiomarkersofalzheimersdisease AT jiuchen casereportcoexistenceofantiampareceptorencephalitisandpositivebiomarkersofalzheimersdisease |
_version_ |
1721338580604813312 |